These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 16494972

  • 1. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection.
    Khawplod P, Wilde H, Sirikwin S, Benjawongkulchai M, Limusanno S, Jaijaroensab W, Chiraguna N, Supich C, Wangroongsarb Y, Sitprija V.
    Vaccine; 2006 Apr 12; 24(16):3084-6. PubMed ID: 16494972
    [Abstract] [Full Text] [Related]

  • 2. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN, Sanjay TV, Mahendra BJ, Suja MS.
    Int J Infect Dis; 2004 May 12; 8(3):175-9. PubMed ID: 15109593
    [Abstract] [Full Text] [Related]

  • 3. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A, Laiskonis A, Balciuniene L, Banzhoff A, Malerczyk C.
    Vaccine; 2006 May 08; 24(19):4116-21. PubMed ID: 16545510
    [Abstract] [Full Text] [Related]

  • 4. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
    Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, Wasi C.
    Bull World Health Organ; 2000 May 08; 78(5):693-8. PubMed ID: 10859864
    [Abstract] [Full Text] [Related]

  • 5. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
    Wongsaroj P, Udomchaisakul P, Tepsumethanon S, Khawplod P, Tantawichien T.
    Vaccine; 2013 Mar 25; 31(13):1748-51. PubMed ID: 23370149
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
    Lang J, Cetre JC, Picot N, Lanta M, Briantais P, Vital S, Le Mener V, Lutsch C, Rotivel Y.
    Biologicals; 1998 Dec 25; 26(4):299-308. PubMed ID: 10403033
    [Abstract] [Full Text] [Related]

  • 7. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.
    Tantawichien T, Benjavongkulchai M, Limsuwan K, Khawplod P, Kaewchompoo W, Chomchey P, Sitprija V.
    Clin Infect Dis; 1999 May 25; 28(5):1100-3. PubMed ID: 10452642
    [Abstract] [Full Text] [Related]

  • 8. Intra-dermal administration of rabies vaccines in developing countries: at an affordable cost.
    Verma R, Khanna P, Prinja S, Rajput M.
    Hum Vaccin; 2011 Jul 25; 7(7):792-4. PubMed ID: 21734465
    [Abstract] [Full Text] [Related]

  • 9. What happens if intradermal injections of rabies vaccine are partially or entirely injected subcutaneously?
    Phanuphak P, Khaoplod P, Benjavongkulchai M, Chutivongse S, Wilde H.
    Bull World Health Organ; 1990 Jul 25; 68(1):83-5. PubMed ID: 2347035
    [Abstract] [Full Text] [Related]

  • 10. A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine.
    Pengsaa K, Limkittikul K, Sabchareon A, Ariyasriwatana C, Chanthavanich P, Attanath P, Malerczyk C.
    Pediatr Infect Dis J; 2009 Apr 25; 28(4):335-7. PubMed ID: 19333080
    [Abstract] [Full Text] [Related]

  • 11. One or three intradermal injections within one week for rabies pre-exposure immunization.
    Khawplod P, Wilde H, Sriaroon C, Chomchey P, Kamolthum T, Sitprija V.
    Dev Biol (Basel); 2008 Apr 25; 131():393-401. PubMed ID: 18634501
    [Abstract] [Full Text] [Related]

  • 12. Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa.
    Sudarshan MK, Madhusudana SN, Mahendra BJ, Narayana DH, Giri MS, Muhamuda K, Ravish HS, Venkatesh GM.
    Natl Med J India; 2006 Apr 25; 19(4):192-4. PubMed ID: 17100105
    [Abstract] [Full Text] [Related]

  • 13. Intradermal pre-exposure rabies immunisation in New Zealand.
    Shaw MM, Leggat PA, Williams ML.
    Travel Med Infect Dis; 2006 Jan 25; 4(1):29-33. PubMed ID: 16887722
    [Abstract] [Full Text] [Related]

  • 14. A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization.
    Shiota S, Khawplod P, Ahmed K, Mifune K, Nishizono A.
    Vaccine; 2008 Nov 25; 26(50):6441-4. PubMed ID: 18804510
    [Abstract] [Full Text] [Related]

  • 15. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.
    Kamoltham T, Thinyounyong W, Phongchamnaphai P, Phraisuwan P, Khawplod P, Banzhoff A, Malerczyk C.
    J Pediatr; 2007 Aug 25; 151(2):173-7. PubMed ID: 17643772
    [Abstract] [Full Text] [Related]

  • 16. Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis.
    Tantawichien T, Tantawichien T, Supit C, Khawplod P, Sitprija V.
    Clin Infect Dis; 2001 Dec 15; 33(12):2085-7. PubMed ID: 11712097
    [Abstract] [Full Text] [Related]

  • 17. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).
    Ashwathnarayana DH, Madhusudana SN, Sampath G, Sathpathy DM, Mankeshwar R, Ravish HH, Ullas PT, Behra TR, Sudarshan MK, Gangaboraiah, Shamanna M.
    Vaccine; 2009 Dec 10; 28(1):148-51. PubMed ID: 19818720
    [Abstract] [Full Text] [Related]

  • 18. Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines.
    Quiambao BP, Ambas C, Diego S, Bosch Castells V, Korejwo J, Petit C, Houillon G.
    Vaccine; 2019 Apr 10; 37(16):2268-2277. PubMed ID: 30890382
    [Abstract] [Full Text] [Related]

  • 19. Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine.
    Beran J, Honegr K, Banzhoff A, Malerczyk C.
    Vaccine; 2005 Jun 10; 23(30):3902-7. PubMed ID: 15917111
    [Abstract] [Full Text] [Related]

  • 20. Postexposure rabies prophylaxis completed in 1 week: preliminary study.
    Shantavasinkul P, Tantawichien T, Wilde H, Sawangvaree A, Kumchat A, Ruksaket N, Lohsoonthorn V, Khawplod P, Tantawichien T.
    Clin Infect Dis; 2010 Jan 01; 50(1):56-60. PubMed ID: 19995217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.